ALVO Stock Analysis Today
Updated Nov 12, 2026 · trends, key levels, insider activity and news
Is ALVO bullish or bearish today?
Daily trend: Downtrend (starting) — turns up above $6.53
SEPT signal: Accumulation · Strong Bearish
Research grade: B+ · fair value $8.00 (+70.2%)
ALVO trend by timeframe
| Daily | Downtrend (starting) |
|---|---|
| 4 hour | Descending Triangle |
| 1 hour | Strong Bearish |
| 15 min | Strong Bullish |
| 5 min | Strong Bearish |
Trends are calculated from price structure and update during market hours.
ALVO support and resistance levels
Resistance (above)
$5.005 touches
$5.397 touches
$5.992 touches
Support (below)
$4.477 touches
$4.184 touches
$3.7711 touches
Upside zones: $6.29 / $6.43 / $6.58
See all levels on the live chart →Latest ALVO news and filings
- EarningsBenzinga
Alvotech posts wider quarterly loss as revenue falls short of estimates
The company reported a third-quarter loss of $0.23 per share, larger than the $0.07 loss analysts projected. Revenue of $111.6 million also came in below the $119.037 million estimate.
- GuidanceBenzinga
Alvotech keeps FY2026 sales guidance at $650M-$700M
Alvotech restated its full-year 2026 sales outlook of $650 million to $700 million. That range sits against an analyst estimate of $651.278 million.
- AnalystFiscal.ai
Jefferies starts Alvotech coverage with Buy rating
Jefferies began covering Alvotech and assigned a Buy rating to the stock. The rating reflects the firm's view on the company's shares.
- AnalystBenzinga
Jefferies starts Alvotech coverage with Buy rating and $9 price target
Jefferies began covering Alvotech and gave the shares a Buy rating. The firm set a $9 price target on the stock.
- ProductFiscal.ai
Alvotech gains FDA clearance for a new production method for Simlandi
Alvotech has received FDA approval for a new manufacturing process for its Simlandi product. The approval allows the company to use this updated method in production.
- ProductBenzinga
Alvotech gets FDA clearance for updated SIMLANDI production method
Alvotech received FDA clearance for a revised way of making SIMLANDI. The company's shares moved up following that news.
- ProductBenzinga
Alvotech gets US regulator clearance for updated SIMLANDI production method
Alvotech's revised manufacturing method for the SIMLANDI drug substance has been cleared by the US regulator. The update more than doubles yield from each batch, with no change to the scale of upstream production.
Live ALVO chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is ALVO bullish or bearish today?
ALVO daily trend: Downtrend (starting) — turns up above $6.53. SEPT signal: Accumulation (Strong Bearish). Updated Nov 12, 2026.
What is ALVO's trend on each timeframe?
Daily: Downtrend (starting); 4 hour: Descending Triangle; 1 hour: Strong Bearish; 15 min: Strong Bullish; 5 min: Strong Bearish.
What are ALVO support and resistance levels?
Support: $4.47, $4.18, $3.77. Resistance: $5.00, $5.39, $5.99. Last price $4.92.
What is the latest news on ALVO?
Nov 11, 2026: Alvotech posts wider quarterly loss as revenue falls short of estimates · Nov 11, 2026: Alvotech keeps FY2026 sales guidance at $650M-$700M · Nov 10, 2026: Jefferies starts Alvotech coverage with Buy rating